iSpecimen secures suppliers for hMPV biospecimens amid China outbreak concerns

iSpecimen Inc.

iSpecimen secured suppliers for human metapneumovirus (hMPV) biospecimens to meet potential demand.
Virus causing hospital overruns in China; no vaccine exists, raising pandemic fears.
Company expects researchers and vaccine developers to require hMPV specimens for study.
iSpecimen leverages its network of hospitals, labs, biobanks to procure specimens globally.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.